X0306 4 2019-09-20 0 0000715446 Anixa Biosciences Inc ANIX 0001683567 Baskies Arnold M C/O ANIXA BIOSCIENCES, INC. 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118 1 0 0 0 Employee Stock Option 0.67 2019-09-20 4 D 0 6000 D 2022-09-22 Common Stock 6000 0 D Employee Stock Option 3.13 2019-09-20 4 A 0 6000 A 2022-09-22 Common Stock 6000 6000 D Employee Stock Option 0.67 2019-09-20 4 D 0 12000 D 2022-09-22 Common Stock 12000 0 D Employee Stock Option 5.3 2019-09-20 4 A 0 12000 A 2022-09-22 Common Stock 12000 12000 D These transactions involved an amendment of outstanding stock options due to a settlement pursuant to which these options that had been repriced on September 6, 2017 to $0.67, would have their exercise price changed to the exercise price immediately prior to that repricing, resulting in the deemed cancellation of the "old" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options. The option was originally granted on August 23, 2016 and vested 50% on September 30, 2016 and 50% on December 31, 2016. The option was originally granted on January 3, 2017 and vests and become exercisable in four (4) equal installments on each March 31, 2017, June 30, 2017, September 30, 2017 and December 31, 2017. /s/ Arnold M. Baskies 2019-09-20